Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessStocks

Hold Sun Pharmaceutical Industries target of Rs 510: Sharekhan

Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 510 in its research report dated May 27, 2020.

May 28, 2020 / 04:35 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sharekhan's research report on Sun Pharmaceutical Industries

Sun Pharma reported healthy results for Q4FY2020; however numbers missed estimates. Sun Pharmaceutical industries (Sun Pharma) is witnessing sustained competitive pressures in the US generic business, which are unlikely to abate in the near to medium term. Also the momentum for the specialty business is likely to slow down in the near term due to covid impact. Domestic formulations, could also witness a slowdown in the current quarter on the back of Covid related issues which could impact the demand due to lower prescriptions written and advance stocking of chronic medicines.


Outlook


Given persistent uncertainties in US business and India business in the near-medium term, we hold back from taking a constructive view and retain a Hold recommendation on the stock with a revised PT of Rs 510.
Read More


For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: May 28, 2020 04:35 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347